St. Antonius ziekenhuis

Nieuwegein 3435CM

9 studies enrolling now · 54 studies all time

What they study most

Abdominal Aortic Aneurysm, Acute Coronary Syndrome, Acute Decompensated Heart Failure, Acute Non-cardioembolic Ischemic Stroke, Aortic Valve Disease, Arrhythmia, Ventricular, Atrial Fibrillation, Atrial Fibrillation (AF), Bleeding, CIED Related Infection, Cardiac Pacemaker, Artificial, Chronic Cough

Studies at this site

• A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma — Recruiting now
• A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis — Recruiting now
• A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast — Recruiting now
• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart — Recruiting now
• A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases — Recruiting now
• A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure — Recruiting now
• Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation — Recruiting now
• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now
• Terumo Aortic Global Endovascular Registry — Recruiting now
• WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment) — Recruiting now
• FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression — Starting soon
• CHAMPION-AF Clinical Trial — Running, not enrolling
• A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease — Completed
• Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing — Running, not enrolling
• Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism — Running, not enrolling
• A Randomised Trial of S-ICD Implantation With and Without Defibrillation Testing — Completed
• Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study — Paused
• Evolut™ EXPAND TAVR II Pivotal Trial — Running, not enrolling
• Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation — Completed
• Amplatzer Amulet LAAO vs. NOAC — Running, not enrolling
• A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI — Running, not enrolling
• Enlighten Study: The EV-ICD Post Approval Registry — Running, not enrolling
• DISSECT-N Post Market Data Collection Registry — Completed
• REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension — Completed
• Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension — Completed
• Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction — Completed
• Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF — Completed
• Evaluation of the Phased Radio Frequency Ablation System — Stopped early
• Extravascular ICD Pivotal Study — Completed
• A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration — Completed
• Cardionomic STOP-ADHF Study — Completed
• Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain. — Completed
• OPTIMIZE IDE for the Treatment of ACS — Stopped early
• REDUCE LAP-HF TRIAL II — Running, not enrolling
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care — Stopped early
• Strategic Management to Optimize Response To Cardiac Resynchronization Therapy — Completed
• The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices — Completed
• Restorelle® Mesh Versus Native Tissue Repair for Prolapse — Completed
• A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF — Stopped early
• World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
• FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT — Completed
• The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions — Completed
• Artificial Valve Endocarditis Reduction Trial — Stopped early
• Tailored Treatment of Permanent Atrial Fibrillation — Completed
• Acute Study to Collect Electrical Signals From the Heart Using a Special Lead — Completed
• REVEAL AF: Incidence of AF in High Risk Patients — Completed
• Safety and Clinical Performance of the Protecta ICD and CRT-D — Completed
• S-ICD® System IDE Clinical Study — Completed
• The CHIPS Trial (Control of Hypertension In Pregnancy Study) — Completed
• A Trial of Routine Aspiration Thrombectomy With Percutaneous Coronary Intervention (PCI) Versus PCI Alone in Patients With ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Primary PCI — Completed